COURTENAY WELLS: Open Payments
NPI 1093824815 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 62 payments from 11 companies in 2025. Trend: 2023 $20 · 2024 $52 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $445 |
| AstraZeneca Pharmaceuticals LP | 6 | $301 |
| Lilly USA, LLC | 8 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| Exact Sciences Corporation | 1 | $75 |
| Amgen Inc. | 4 | $71 |
| Novo Nordisk Inc | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $52 |
| Lundbeck LLC | 3 | $48 |
Products named: VRAYLAR, CAPLYTA, QULIPTA, BREZTRI, AIRSUPRA, MOUNJARO, ZEPBOUND, Kerendia.
Industry payments across IN — which companies pay providers there.
